STORM Therapeutics Limited

📍 Cambridge, United Kingdom🗓 Founded 2015👥 36 employees💰 Last funded Jun 2019
Biotechnology Research🌐 stormtherapeutics.com
Website LinkedIn
STORM Therapeutics is a biotechnology company creating novel therapies that inhibit RNA modifying enzymes (RME) for use in oncology and other diseases. There are more than 150 RNA modifications reported and approximately 300 RNA modifying enzymes which represent novel therapeutic targets. STORM has leveraged its first mover advantage to establish a novel drug discovery and RNA analytics platform leading to the identification of novel targets and a proprietary pipeline of first in class small-molecule drug candidates for potential use in oncology, inflammation, viral infections, and CNS diseases. The pipeline is exemplified by STORM’s METTL3 inhibitor (STC-15) for which an IND has been filed with the FDA to support initiation of a Phase I clinical trial in cancer patients in 2022. STC-15 represents the first RNA modifying enzyme inhibitor to enter clinical evaluation in humans. Additional candidates are planned for advancement into IND-track activities in 2023. STORM has built an experienced R&D team who occupy modern, well-equipped laboratories on the Babraham Research Campus near Cambridge, UK. The company’s proprietary in house research is complemented by outsourcing of some discovery activities to high quality CRO partners (e.g., Evotec) enabling STORM to operate a cost efficient and flexible model.
5
Total investors
2
Early stage
3
Mid stage
0
Late stage
2015
Founded

Investors

5 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United Kingdom
4
Netherlands
1
Investor activity2015–2019 · investors recorded per year
201522018120192
Recent (last 2y)Earlier
Frequently asked questions
Who invested in STORM Therapeutics Limited?
STORM Therapeutics Limited has 5 investors on record on gritt.io, including 2 early-stage backers, 3 mid-stage.
When did STORM Therapeutics Limited last raise funding?
The most recent investment in STORM Therapeutics Limited recorded on gritt.io was in June 2019.
When was STORM Therapeutics Limited founded?
STORM Therapeutics Limited was founded in 2015.
What industry is STORM Therapeutics Limited in?
STORM Therapeutics Limited operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is STORM Therapeutics Limited based?
STORM Therapeutics Limited is headquartered in Cambridge, United Kingdom.